Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	multi-eIF complex	EIF1AY EIF1AX	1.58e-04	4	108	2	GO:0043614
MousePheno	increased heart ventricle muscle contractility	PDC OBSCN AKAP12 IGF1	2.52e-06	16	88	4	MP:0005600
MousePheno	increased heart left ventricle muscle contractility	OBSCN AKAP12 IGF1	1.32e-05	8	88	3	MP:0031635
Domain	TIF_eIF-1A_CS	EIF1AY EIF1AX	3.19e-05	2	106	2	IPR018104
Domain	TIF_eIF-1A	EIF1AY EIF1AX	9.54e-05	3	106	2	PD005579
Domain	IF1A	EIF1AY EIF1AX	9.54e-05	3	106	2	PS01262
Domain	RCC1	MYCBP2 RCC2 HERC5	1.89e-04	20	106	3	PF00415
Domain	S1_IF1_TYPE	EIF1AY EIF1AX	1.90e-04	4	106	2	PS50832
Domain	TIF_eIF-1A	EIF1AY EIF1AX	1.90e-04	4	106	2	IPR001253
Domain	eIF1a	EIF1AY EIF1AX	1.90e-04	4	106	2	SM00652
Domain	RNA-binding_domain_S1_IF1	EIF1AY EIF1AX	1.90e-04	4	106	2	IPR006196
Domain	eIF-1a	EIF1AY EIF1AX	1.90e-04	4	106	2	PF01176
Domain	RCC1_1	MYCBP2 RCC2 HERC5	2.19e-04	21	106	3	PS00625
Domain	RCC1_2	MYCBP2 RCC2 HERC5	2.19e-04	21	106	3	PS00626
Domain	RCC1_3	MYCBP2 RCC2 HERC5	2.19e-04	21	106	3	PS50012
Domain	-	MYCBP2 RCC2 HERC5	2.53e-04	22	106	3	2.130.10.30
Domain	Reg_chr_condens	MYCBP2 RCC2 HERC5	2.53e-04	22	106	3	IPR000408
Domain	G_PATCH	RBM10 GPATCH8 SUGP2	2.90e-04	23	106	3	PS50174
Domain	G_patch	RBM10 GPATCH8 SUGP2	2.90e-04	23	106	3	SM00443
Domain	G_patch_dom	RBM10 GPATCH8 SUGP2	2.90e-04	23	106	3	IPR000467
Domain	G-patch	RBM10 GPATCH8 SUGP2	2.90e-04	23	106	3	PF01585
Domain	RCC1/BLIP-II	MYCBP2 RCC2 HERC5	2.90e-04	23	106	3	IPR009091
Domain	Alpha_kinase	ALPK3 ALPK2	4.72e-04	6	106	2	PF02816
Domain	MHCK_EF2_kinase	ALPK3 ALPK2	4.72e-04	6	106	2	IPR004166
Domain	ALPHA_KINASE	ALPK3 ALPK2	4.72e-04	6	106	2	PS51158
Domain	Alpha_kinase	ALPK3 ALPK2	4.72e-04	6	106	2	SM00811
Domain	Transl_elong_EFTu/EF1A_C	GTPBP1 GSPT2	8.74e-04	8	106	2	IPR004160
Domain	GTP_EFTU_D3	GTPBP1 GSPT2	8.74e-04	8	106	2	PF03143
Domain	PH	TRIO ARHGAP23 TBC1D2 OBSCN SPTBN5 ARHGEF40 ACAP2	1.04e-03	278	106	7	SM00233
Domain	PH_DOMAIN	TRIO ARHGAP23 TBC1D2 OBSCN SPTBN5 ARHGEF40 ACAP2	1.07e-03	279	106	7	PS50003
Domain	PH_domain	TRIO ARHGAP23 TBC1D2 OBSCN SPTBN5 ARHGEF40 ACAP2	1.09e-03	280	106	7	IPR001849
Domain	Transl_elong_EF1A/Init_IF2_C	GTPBP1 GSPT2	1.39e-03	10	106	2	IPR009001
Domain	-	TRIO ARHGAP23 TBC1D2 OBSCN SPTBN5 ARHGEF40 ACAP2 EPB41L1	1.74e-03	391	106	8	2.30.29.30
Domain	PH_dom-like	TRIO ARHGAP23 TBC1D2 OBSCN SPTBN5 ARHGEF40 ACAP2 EPB41L1	2.95e-03	426	106	8	IPR011993
Domain	Acyl_Trfase/lysoPLipase	FASN PLA2G4A	4.10e-03	17	106	2	IPR016035
Domain	EFTu-like_2	GTPBP1 GSPT2	4.60e-03	18	106	2	IPR004161
Domain	GTP_EFTU_D2	GTPBP1 GSPT2	4.60e-03	18	106	2	PF03144
Domain	G_TR_2	GTPBP1 GSPT2	4.60e-03	18	106	2	PS51722
Domain	TF_GTP-bd_dom	GTPBP1 GSPT2	5.12e-03	19	106	2	IPR000795
Domain	DH_1	TRIO OBSCN ARHGEF40	5.51e-03	63	106	3	PS00741
Pubmed	Human transcription factor protein interaction networks.	ZHX3 ASXL1 RB1 CNOT10 RBM10 DIDO1 CEP192 SSB GPATCH8 BCL7A GTPBP1 RFX5 RCC2 IKZF5 G3BP1 SUGP2 TTC31 BANP MARF1 EHMT1 GIGYF2 CABIN1 TP53BP1 PRRC2B TBL1X	2.27e-12	1429	110	25	35140242
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ZHX3 RPS6KA5 TCOF1 MYCBP2 RBM10 TBC1D2 DIDO1 GPATCH8 WRAP53 FASN MDN1 G3BP1 SUGP2 PLA2G4A GIGYF2 TP53BP1 WDR62	3.80e-10	774	110	17	15302935
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MIA3 ANK3 TRIO TCOF1 MYCBP2 DIDO1 GOLGA8K AKAP12 MDN1 G3BP1 EHMT1 GIGYF2 CABIN1 EPB41L1 TP53BP1 PRRC2B TBL1X	9.94e-09	963	110	17	28671696
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TCOF1 MYCBP2 DIDO1 SSB RCC2 FASN MDN1 G3BP1 SUGP2 GIGYF2 MED12 TP53BP1 PRRC2B HERC5	2.07e-08	653	110	14	22586326
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZHX3 MYCBP2 KNSTRN RBM10 DIDO1 SSB GTPBP1 RFX5 RCC2 IKZF5 FASN G3BP1 SUGP2 EHMT1 MED12 TP53BP1 PRRC2B	7.09e-08	1103	110	17	34189442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TBC1D9B TRIO MYCBP2 OBSCN GBX2 CEP192 BCL7A WRAP53 FASN ARHGEF40 MDN1 SUGP2 BANP EHMT1 CABIN1 MED12 PRRC2B	7.27e-08	1105	110	17	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZHX3 ASXL1 RBM10 ZBTB43 CAMTA2 CEP192 GPATCH8 SUGP2 GIGYF2 EPB41L1 PRRC2B	7.45e-08	407	110	11	12693553
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZHX3 TCOF1 RBM10 DIDO1 TACC2 RCC2 AKAP12 FASN G3BP1 SUGP2 GIGYF2 TP53BP1 PRRC2B WDR62 HERC5	2.67e-07	934	110	15	33916271
Pubmed	PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.	MYCBP2 GOLGA8R CEP192 MDN1 G3BP1 SUGP2 EIF1AX WDR62	1.27e-06	247	110	8	32989298
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ANK3 TCOF1 MYCBP2 RBM10 DIDO1 FASN SUGP2 GIGYF2 MED12 TP53BP1 PRRC2B	1.43e-06	549	110	11	38280479
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	ASXL1 CNOT10 KNSTRN TACC2 CEP192 SSB BCL7A WRAP53 AKAP12 FASN ZNHIT6 EHMT1 TP53BP1 PRRC2B WDR62	3.71e-06	1155	110	15	20360068
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	ZHX3 TCOF1 RBM10 SSB GPATCH8 G3BP1 EIF1AX TP53BP1 TBL1X	5.27e-06	399	110	9	35987950
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MYCBP2 DIDO1 TACC2 SSB GTPBP1 RCC2 MDN1 G3BP1 SUGP2 ZNF358 MED12 HERC5	5.35e-06	759	110	12	35915203
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MIA3 ARHGAP23 DIDO1 GTPBP1 RCC2 ARHGEF40 ZNHIT6 MARF1 GIGYF2 EPB41L1 PRRC2B	7.15e-06	650	110	11	38777146
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYCBP2 EIF1AY FASN ZNF532 GIGYF2 MED12 WDR62 TBL1X S100PBP	7.65e-06	418	110	9	34709266
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	TCOF1 TNC RBM10 SSB GPATCH8 RCC2 EIF1AY G3BP1 GIGYF2	7.95e-06	420	110	9	28065597
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	TCOF1 DIDO1 SSB GPATCH8 RCC2 FASN GSPT2 G3BP1 SUGP2 EIF1AX GIGYF2 PRRC2B	9.89e-06	807	110	12	22681889
Pubmed	Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor.	RB1 TP53BP1	9.91e-06	2	110	2	25049398
Pubmed	Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.	DDR1 FGF14	9.91e-06	2	110	2	32776088
Pubmed	A transgenic mouse model for early prostate metastasis to lymph nodes.	RB1 AKAP12	9.91e-06	2	110	2	24492704
Pubmed	Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors.	RB1 ITGA10	9.91e-06	2	110	2	24287699
Pubmed	Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.	RBM10 MED12	9.91e-06	2	110	2	28634282
Pubmed	Binding of an interferon-inducible protein (p202) to the retinoblastoma protein.	RB1 TP53BP1	9.91e-06	2	110	2	7890747
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	TCOF1 GTPBP1 MDN1 SUGP2 GIGYF2 PRRC2B HERC5	1.59e-05	251	110	7	28077445
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	RB1 RBM10 ZBTB43 GTPBP1 RCC2 IKZF5 BANP EHMT1 ACAP2 TP53BP1	1.70e-05	583	110	10	29844126
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ANK3 MYCBP2 RB1 CNOT10 PTDSS2 SSB AKAP12 MARF1 GIGYF2 ACAP2 BBS12 TP53BP1 PRRC2B WDR62 CCDC40	1.82e-05	1321	110	15	27173435
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DDR1 MIA3 ANK3 TRIO MYCBP2 OBSCN CEP192 ABCG1 IGF1 SUGP2 ZNF532 BANP EHMT1 MLPH EPB41L1 TBL1X	1.84e-05	1489	110	16	28611215
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	MIA3 TCOF1 DIDO1 AKAP12 OPTN GSPT2 ACAP2 TP53BP1	2.00e-05	360	110	8	33111431
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	DIDO1 MDN1 SUGP2 CABIN1 EPB41L1	2.07e-05	104	110	5	9205841
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TRIO ARHGAP23 RPS6KA5 SSB RCC2 CFB NMT2 TP53BP1 PRRC2B	2.10e-05	475	110	9	31040226
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZHX3 RBM10 BCL7A RFX5 MED12 PRRC2B TBL1X	2.41e-05	268	110	7	33640491
Pubmed	Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16.	CXCL16 IL33	2.97e-05	3	110	2	30467418
Pubmed	Upregulation of IL-33, CCL2, and CXCL16 levels in Brazilian pregnant women infected by Toxoplasma gondii.	CXCL16 IL33	2.97e-05	3	110	2	37086937
Pubmed	Stress and IGF-I differentially control cell fate through mammalian target of rapamycin (mTOR) and retinoblastoma protein (pRB).	RB1 IGF1	2.97e-05	3	110	2	18697743
Pubmed	PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.	RB1 AKAP12	2.97e-05	3	110	2	37875657
Pubmed	CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells.	RB1 TP53BP1	2.97e-05	3	110	2	32687165
Pubmed	Tenascin-C expression during wallerian degeneration in C57BL/Wlds mice: possible implications for axonal regeneration.	RB1 TNC	2.97e-05	3	110	2	7539482
Pubmed	The interaction between eukaryotic initiation factor 1A and eIF5 retains eIF1 within scanning preinitiation complexes.	EIF1AY EIF1AX	2.97e-05	3	110	2	24319994
Pubmed	Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.	RB1 SSB GTPBP1 IFIH1 OPTN TXLNB PRRC2B	3.42e-05	283	110	7	21903422
Pubmed	Inhibition of E2F-mediated transcription by p202.	RB1 TP53BP1	5.92e-05	4	110	2	8896460
Pubmed	Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.	CFB HPX	5.92e-05	4	110	2	26908325
Pubmed	The protein interaction landscape of the human CMGC kinase group.	ASXL1 TCOF1 RB1 DIDO1 GPATCH8 EIF1AY SUGP2 MED12 EPB41L1 WDR62	7.43e-05	695	110	10	23602568
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	MIA3 TCOF1 MYCBP2 RBM10 SSB GPATCH8 G3BP1 TP53BP1	8.19e-05	440	110	8	34244565
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ASXL1 RB1 FASN MDN1 SUGP2 BANP PLA2G4A CABIN1 TP53BP1 HERC5 TBL1X	8.87e-05	857	110	11	25609649
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ASXL1 TRIO TBC1D2 FASN EIF1AX ALPK2 PRRC2B	9.31e-05	332	110	7	37433992
Pubmed	Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases.	RPS6KA5 PLA2G4A	9.85e-05	5	110	2	10978317
Pubmed	Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells.	ETS2 IGF1	9.85e-05	5	110	2	27989801
Pubmed	PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.	ABCG1 IGF1	9.85e-05	5	110	2	22503545
Pubmed	Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene.	RB1 IGF1	9.85e-05	5	110	2	9819431
Pubmed	Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription.	RB1 ZBTB18	9.85e-05	5	110	2	11350943
Pubmed	Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling.	IGF1 GIGYF2	9.85e-05	5	110	2	12771153
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MYCBP2 CNOT10 GTPBP1 AKAP12 G3BP1 SUGP2 MARF1 EHMT1 GIGYF2 PRRC2B	1.04e-04	724	110	10	36232890
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ZHX3 TCOF1 RBM10 DIDO1 G3BP1 MED12 TP53BP1	1.10e-04	341	110	7	32971831
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	TCOF1 KNSTRN DIDO1 SSB WRAP53 GTPBP1 C2orf68 FASN ARHGEF40 GZF1 G3BP1 SUGP2 MARF1 PRRC2B	1.10e-04	1371	110	14	36244648
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	DDR1 ARHGAP23 MYCBP2 OBSCN DIDO1 TACC2 GPATCH8 C2orf68 BANP MARF1 USP35 ZBTB18 PRRC2B	1.25e-04	1215	110	13	15146197
Pubmed	Systematic identification of factors for provirus silencing in embryonic stem cells.	RCC2 AKAP12 MDN1 TP53BP1 TBL1X	1.30e-04	153	110	5	26365490
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	RBM10 DIDO1 RCC2 FASN SUGP2 EHMT1 PRRC2B	1.46e-04	357	110	7	37059091
Pubmed	The proximity ligation assay reveals that at DNA double-strand breaks WRAP53β associates with γH2AX and controls interactions between RNF8 and MDC1.	WRAP53 TP53BP1	1.47e-04	6	110	2	26734725
Pubmed	Structural basis for the nuclear export activity of Importin13.	EIF1AY EIF1AX	1.47e-04	6	110	2	23435562
Pubmed	GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling.	IGF1 GIGYF2	1.47e-04	6	110	2	19744960
Pubmed	SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.	IFIH1 G3BP1	1.47e-04	6	110	2	35075101
Pubmed	Alpha-kinases: a new class of protein kinases with a novel catalytic domain.	ALPK3 ALPK2	1.47e-04	6	110	2	10021370
Pubmed	DHHC protein family targets different subsets of glioma stem cells in specific niches.	IGF1 GSPT2 TBL1X	1.57e-04	33	110	3	30658672
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	TCOF1 MYCBP2 RBM10 DIDO1 GPATCH8 BCL7A RCC2 SUGP2 ZNF532 EIF1AX EHMT1 MED12	1.66e-04	1082	110	12	38697112
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	TCOF1 RBM10 DIDO1 FASN PLA2G4A GIGYF2	1.70e-04	256	110	6	33397691
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ZHX3 ANK3 OBSCN IFIH1 MDN1 HPX GIGYF2 MED12	1.89e-04	497	110	8	36774506
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	MIA3 ANK3 RBM10 G3BP1 GIGYF2 PRRC2B	1.96e-04	263	110	6	34702444
Pubmed	Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5.	RB1 ETS2	2.06e-04	7	110	2	12860972
Pubmed	Cloning and expression analysis of the mouse stroma marker Snep encoding a novel nidogen domain protein.	NID2 TNC	2.06e-04	7	110	2	15162516
Pubmed	Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis.	RB1 IGF1	2.06e-04	7	110	2	14681231
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MYCBP2 RB1 CNOT10 RFX5 RCC2 HPX CABIN1 ACAP2 MED12	2.16e-04	645	110	9	25281560
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MIA3 TRIO TCOF1 MYCBP2 DIDO1 AKAP12 FASN OPTN ARHGEF40 G3BP1 EHMT1 TP53BP1 PRRC2B	2.36e-04	1297	110	13	33545068
Pubmed	Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin.	TNC CXCL16 IL33	2.40e-04	38	110	3	27653694
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZHX3 RBM10 ZBTB43 ETS2 DIDO1 GBX2 RFX5 IKZF5 ZSCAN20 SOX21	2.51e-04	808	110	10	20412781
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CNOT10 DIDO1 GPATCH8 BCL7A WRAP53 RCC2 RFTN1 MDN1 GZF1 EIF1AX NMT2 EHMT1 MED12 EPB41L1	2.72e-04	1497	110	14	31527615
Pubmed	Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.	ANK3 OBSCN	2.74e-04	8	110	2	28826662
Pubmed	SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors.	NID2 TNC	2.74e-04	8	110	2	21349332
Pubmed	A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities.	CFB IFIH1 RFTN1 TTC31 ZNF358	2.77e-04	180	110	5	24104479
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	OBSCN CEP192 ZNF532 CCDC40	3.05e-04	101	110	4	10997877
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	RBM10 TBC1D2 CEP192 RFX5 GIGYF2	3.07e-04	184	110	5	32908313
Pubmed	Functional dissection of Rab GTPases involved in primary cilium formation.	TBC1D9B TBC1D2 OPTN	3.46e-04	43	110	3	17646400
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	ASXL1 TCOF1 MYCBP2 CNOT10 CEP192 ATE1 OPTN G3BP1 GIGYF2 TP53BP1 PRRC2B	3.51e-04	1005	110	11	19615732
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	ANK3 RB1 AKAP12 OPTN TP53BP1	3.64e-04	191	110	5	20195357
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	TCOF1 RBM10 SSB FASN MDN1 G3BP1 SUGP2 EHMT1 GIGYF2 WDR62	3.65e-04	847	110	10	35850772
Pubmed	Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.	CFB FASN HPX	3.71e-04	44	110	3	31273033
Pubmed	A non-proteolytic role for ubiquitin in deadenylation of MHC-I mRNA by the RNA-binding E3-ligase MEX-3C.	MYCBP2 GTPBP1 GIGYF2	3.71e-04	44	110	3	26471122
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ZHX3 RB1 DIDO1 GPATCH8 FASN MDN1 SUGP2 ZNF532 EHMT1 POLD4 MED12	3.78e-04	1014	110	11	32416067
Pubmed	Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.	CNOT10 G3BP1 TTC31 GIGYF2	3.81e-04	107	110	4	30995489
Pubmed	A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.	MYCBP2 ATE1 MDN1 G3BP1 GIGYF2 PRRC2B	3.82e-04	298	110	6	32353859
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	NID2 CNOT10 RCC2 OPTN G3BP1 GIGYF2	4.10e-04	302	110	6	30561431
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ANK3 TCOF1 ATE1 RCC2 AKAP12 FASN GIGYF2 MED12 EPB41L1	4.26e-04	708	110	9	39231216
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZHX3 ZBTB43 ETS2 DIDO1 TACC2 SOX21 ZNF532 ZNF358 ZBTB18	4.31e-04	709	110	9	22988430
Pubmed	LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 From Degradation in the Epithelial Ovarian Cancer.	RCC2 FASN	4.39e-04	10	110	2	33282727
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	TCOF1 MYCBP2 FASN ARHGEF40 GIGYF2	4.70e-04	202	110	5	24639526
Pubmed	An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture.	SSB G3BP1 TBL1X	4.80e-04	48	110	3	17620012
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	NID2 TCOF1 GIGYF2 TP53BP1 PRRC2B	4.80e-04	203	110	5	22083510
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	RBM10 SSB GTPBP1 EIF1AY FASN MDN1 G3BP1 NMT2 GIGYF2	5.06e-04	725	110	9	27025967
Pubmed	A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.	CFB IFIH1	5.35e-04	11	110	2	19838195
Pubmed	Identification and comparative analysis of hepatitis C virus-host cell protein interactions.	MYCBP2 OPTN	5.35e-04	11	110	2	24136289
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	NID2 TNC	5.35e-04	11	110	2	38303699
Interaction	CPEB1 interactions	CNOT10 GTPBP1 FASN SUGP2 TTC31 MARF1 GIGYF2 PRRC2B	1.20e-06	146	108	8	int:CPEB1
Interaction	RNF214 interactions	CNOT10 CEP192 FASN G3BP1 TTC31 GIGYF2 PRRC2B	1.45e-06	104	108	7	int:RNF214
Interaction	SIRT7 interactions	TCOF1 MYCBP2 RB1 DIDO1 SSB RCC2 FASN MDN1 G3BP1 SUGP2 GIGYF2 MED12 TP53BP1 PRRC2B HERC5	1.01e-05	744	108	15	int:SIRT7
Interaction	TOP3B interactions	TBC1D9B TRIO MYCBP2 CNOT10 OBSCN GBX2 CEP192 BCL7A WRAP53 GTPBP1 FASN ARHGEF40 MDN1 G3BP1 SUGP2 BANP EHMT1 CABIN1 MED12 TP53BP1 PRRC2B	3.03e-05	1470	108	21	int:TOP3B
Interaction	CEBPA interactions	ZHX3 ASXL1 MYCBP2 RB1 KNSTRN RBM10 DIDO1 SSB GTPBP1 RFX5 RCC2 IKZF5 FASN G3BP1 SUGP2 EHMT1 MED12 TP53BP1 PRRC2B	3.16e-05	1245	108	19	int:CEBPA
Interaction	PATL1 interactions	MIA3 CNOT10 CEP192 GTPBP1 MARF1 PRRC2B WDR62	4.73e-05	177	108	7	int:PATL1
Interaction	CYTOR interactions	RCC2 FASN BANP	5.22e-05	14	108	3	int:CYTOR
Interaction	NAA40 interactions	ZHX3 TCOF1 RBM10 DIDO1 TACC2 RCC2 AKAP12 FASN OPTN G3BP1 SUGP2 GIGYF2 TP53BP1 PRRC2B WDR62 HERC5	6.40e-05	978	108	16	int:NAA40
Interaction	HELZ interactions	RB1 CNOT10 WRAP53 CRYBB3 FASN G3BP1 MARF1 PRRC2B	7.36e-05	257	108	8	int:HELZ
Interaction	NSMCE1 interactions	MAGEF1 FASN ZNHIT6 TP53BP1	7.46e-05	42	108	4	int:NSMCE1
Interaction	AR interactions	ZHX3 ASXL1 MYCBP2 RB1 RBM10 DIDO1 SSB BCL7A RFX5 RCC2 MDN1 G3BP1 SUGP2 MED12 PRRC2B TBL1X	7.56e-05	992	108	16	int:AR
Interaction	SMG6 interactions	CEP192 WRAP53 GTPBP1 C2orf68 PRRC2B	9.40e-05	85	108	5	int:SMG6
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	RBM10 GPATCH8 SUGP2	8.47e-05	22	71	3	579
Coexpression	PILON_KLF1_TARGETS_UP	NID2 ANK3 TRIO PTDSS2 IRAG1 CFB SUGP2 HPX PCSK7 GIGYF2 MLPH	8.23e-06	503	109	11	M2226
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZHX3 ASXL1 TRIO MYCBP2 RB1 GPATCH8 RFTN1 MDN1 NMT2 GIGYF2 ACAP2 ZBTB18 TP53BP1 TBL1X	1.28e-05	856	109	14	M4500
Coexpression	PILON_KLF1_TARGETS_UP	NID2 ANK3 TRIO PTDSS2 IRAG1 CFB SUGP2 HPX PCSK7 GIGYF2 MLPH	1.62e-05	541	109	11	MM1061
Coexpression	GSE3982_DC_VS_BASOPHIL_DN	MIA3 ETS2 DIDO1 C2orf68 MAGEF1 ZNF358 S100PBP	2.03e-05	199	109	7	M5473
Coexpression	GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN	TBC1D9B TRIO TCOF1 FASN ABCG1 TP53BP1 PRRC2B	2.09e-05	200	109	7	M6583
Coexpression	GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	RPS6KA5 CAMTA2 C2orf68 ABCG1 MDN1 MED12 TP53BP1	2.09e-05	200	109	7	M6004
Coexpression	FORTSCHEGGER_PHF8_TARGETS_DN	ZHX3 OBSCN TACC2 MAGEF1 AKAP12 EIF1AY IFIH1 RFTN1 OPTN FAM174A EIF1AX EPB41L1 PRRC2B	2.28e-05	783	109	13	M2488
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	NID2 ASXL1 TRIO ARHGAP23 WRAP53 AKAP12 RFTN1 ARHGEF40 NMT2 ALPK2	2.50e-05	465	109	10	M9192
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	ZHX3 TRIO MYCBP2 RB1 RFTN1 MDN1 NMT2 MARF1 GIGYF2 TBL1X	2.54e-05	466	109	10	M13522
Coexpression	GROSS_HYPOXIA_VIA_ELK3_DN	RPS6KA5 TNC AKAP12 GSPT2 GZF1 ACAP2	4.76e-05	155	109	6	M1304
Coexpression	GROSS_HYPOXIA_VIA_ELK3_DN	RPS6KA5 TNC AKAP12 GSPT2 GZF1 ACAP2	5.68e-05	160	109	6	MM1126
Coexpression	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	BCL7A IRAG1 CFB AKAP12 IGF1	8.61e-05	107	109	5	M4913
Coexpression	GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP	ANK3 TACC2 CFB IFIH1 OPTN HERC5	9.62e-05	176	109	6	M2981
Coexpression	SUNG_METASTASIS_STROMA_UP	TRIO TNC RFX5 EIF1AY PRRC2B	9.81e-05	110	109	5	M9483
Coexpression	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP	DIDO1 TACC2 IGF1 CABIN1 ACAP2 S100PBP	1.06e-04	179	109	6	M8828
Coexpression	GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP	RPS6KA5 DIDO1 RFTN1 NMT2 BANP PRRC2B	1.26e-04	185	109	6	M5643
Coexpression	GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP	BPESC1 IFIH1 RFTN1 G3BP1 MLPH HERC5	1.59e-04	193	109	6	M9233
Coexpression	GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN	C2orf68 OPTN MARF1 USP35 PRRC2B S100PBP	1.68e-04	195	109	6	M7410
Coexpression	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP	ITGA10 GPATCH8 ZNF532 PCSK7 GIGYF2 PRRC2B	1.83e-04	198	109	6	M5580
Coexpression	GSE3982_MAC_VS_BASOPHIL_DN	MIA3 ETS2 RFX5 C2orf68 EIF1AY CRYBB3	1.83e-04	198	109	6	M5498
Coexpression	GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP	MIA3 RFX5 ABCG1 OPTN SCN4A MARF1	1.88e-04	199	109	6	M9420
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	DDR1 CNOT10 ETS2 IFIH1 ABCG1 TP53BP1	1.88e-04	199	109	6	M9184
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	DDR1 ETS2 PTDSS2 IFIH1 ABCG1 TP53BP1	1.88e-04	199	109	6	M9180
Coexpression	GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	PDC TACC2 RFX5 AKAP12 RFTN1 EPB41L1	1.88e-04	199	109	6	M6079
Coexpression	GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP	MYCBP2 ETS2 RCC2 FASN ABCG1 MDN1	1.93e-04	200	109	6	M5819
Coexpression	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	RPS6KA5 SSB BCL7A ADCYAP1 MARF1 MED12	1.93e-04	200	109	6	M5168
Coexpression	GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN	RPS6KA5 GTPBP1 CFB IFIH1 OPTN HERC5	1.93e-04	200	109	6	M9586
Coexpression	GSE42021_TREG_VS_TCONV_PLN_UP	RPS6KA5 GTPBP1 CFB IFIH1 OPTN HERC5	1.93e-04	200	109	6	M9572
Coexpression	GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN	ETS2 GTPBP1 CFB IFIH1 OPTN HERC5	1.93e-04	200	109	6	M9570
Coexpression	GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	KNSTRN CAMTA2 FAM174A G3BP1 PLA2G4A S100PBP	1.93e-04	200	109	6	M7174
Coexpression	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	ZBTB43 GOLGA8K RCC2 CFB IFIH1 EPB41L1 S100PBP	2.10e-04	289	109	7	MM1238
Coexpression	LIU_PROSTATE_CANCER_DN	ARHGAP23 ETS2 IRAG1 C2orf68 AKAP12 OPTN ARHGEF40 IL33 S100PBP	2.21e-04	493	109	9	M19391
Coexpression	GROSS_HYPOXIA_VIA_ELK3_UP	BCL7A RCC2 EIF1AY FASN ABCG1 EIF1AX	2.71e-04	213	109	6	MM1125
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DDR1 ANK3 TNC TBC1D2 OBSCN ETS2 IL33 EPB41L1	3.68e-08	200	110	8	9da214f756a03516eaafde00289b90f69623b9f3
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	NID2 TNC AKAP12 RFTN1 IGF1 PLA2G4A IL33	6.24e-07	198	110	7	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	NID2 TNC AKAP12 RFTN1 ABCG1 ALPK2	4.41e-06	172	110	6	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA5 GPATCH8 C2orf68 NMT2 MARF1 POLD4	5.54e-06	179	110	6	69c74b2ff43b43653005807654953daf21f932ec
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRIO TNC ETS2 TACC2 IGF1 FGF14	6.10e-06	182	110	6	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TBC1D2 ETS2 CXCL16 ABCG1 POLD4 MLPH	6.29e-06	183	110	6	ff751a97466807bf04b5a0740138c61e298cd1fc
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRIO ETS2 CFB IFIH1 OPTN HERC5	6.29e-06	183	110	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 ARHGAP23 AKAP12 RFTN1 ABCG1 ALPK2	6.70e-06	185	110	6	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 ARHGAP23 AKAP12 RFTN1 ABCG1 ALPK2	6.70e-06	185	110	6	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 ARHGAP23 AKAP12 RFTN1 ABCG1 ALPK2	7.34e-06	188	110	6	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 ARHGAP23 AKAP12 RFTN1 ABCG1 ALPK2	7.34e-06	188	110	6	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ABRA ANK3 OBSCN TACC2 ALPK3 ALPK2	7.57e-06	189	110	6	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ABRA ANK3 OBSCN TACC2 ALPK3 ALPK2	7.80e-06	190	110	6	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	BAL-Severe-Myeloid-TRAM\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CXCL16 ABCG1 IGF1 ALPK3 MLPH EPB41L1	8.03e-06	191	110	6	4c4f50a502e3f6768a89df686fa2830b83b8b33f
ToppCell	BAL-Severe-Myeloid-TRAM\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CXCL16 ABCG1 IGF1 ALPK3 MLPH EPB41L1	8.03e-06	191	110	6	de7c88bb46f794291025ef121a89fcd94dea4ffe
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	TCOF1 RCC2 MDN1 SUGP2 PRRC2B WDR62	8.28e-06	192	110	6	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	COVID-19-Myeloid-TRAM2\|COVID-19 / Condition, Lineage and Cell class	CXCL16 ABCG1 IGF1 ALPK3 MLPH HERC5	8.78e-06	194	110	6	c5bdf2b58c10dcb09797ddaf46b2e6c80d10399f
ToppCell	COVID-19-Myeloid-TRAM2\|Myeloid / Condition, Lineage and Cell class	CXCL16 ABCG1 IGF1 ALPK3 MLPH HERC5	8.78e-06	194	110	6	4060a60c0271e7397b07993a1ef47b3291bba6e3
ToppCell	HSPCs-Mk_prog.\|World / Lineage and Cell class	OBSCN GBX2 IRAG1 G3BP1 SUGP2 PLA2G4A	8.78e-06	194	110	6	5049f4f102844d766eca577e809cf21f7908a9d2
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 ARHGAP23 TNC AKAP12 ABCG1 ALPK2	9.31e-06	196	110	6	023477a499a2c190f363cfdbc9d9c646733a6541
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 ARHGAP23 TNC AKAP12 ABCG1 ALPK2	9.31e-06	196	110	6	3cb74f1a333a82cac2b459f2f1517e2acf22b5fd
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DDR1 ETS2 GPATCH8 AKAP12 CABIN1 ALPK2	1.01e-05	199	110	6	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	NID2 TNC AKAP12 RFTN1 PLA2G4A IL33	1.01e-05	199	110	6	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	PBMC-Severe-cDC_9\|Severe / Compartment, Disease Groups and Clusters	ETS2 SSB MAGEF1 EIF1AY IFIH1 HERC5	1.04e-05	200	110	6	ea3b22126d9dfd158bb3c3e1323b30514d721ded
ToppCell	NS-moderate-d_07-13-Myeloid-Mast_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RPS6KA5 ADCYAP1 AKAP12 ARHGEF40 NMT2	4.29e-05	156	110	5	17c38d3b03fc38cb125cf0d165b2fd694cd88edd
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)--\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	KNSTRN OBSCN GBX2 SPTBN5	5.61e-05	84	110	4	43e77117579290446a7e386c0be3459d652d9384
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	KNSTRN OBSCN GBX2 SPTBN5	5.61e-05	84	110	4	38a457a20701fe23c6326b7282cd0993cdd87082
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	KNSTRN OBSCN GBX2 SPTBN5	5.61e-05	84	110	4	59d0415bb6b6b18a94d2c9c6289fa9cbcb2166e3
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CXCL16 CFB ABCG1 IGF1 EPB41L1	5.76e-05	166	110	5	b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK3 TNC IL33 ALPK2 CCDC40	6.27e-05	169	110	5	559e98216720e4babf0b0941100f1b485c35b11b
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MIA3 BPESC1 IFIH1 TXLNB HERC5	6.45e-05	170	110	5	07b561cd9c528bc8444c9385e1de621eee7b697e
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TRIO ETS2 CXCL16 AKAP12 ALPK2	6.45e-05	170	110	5	cc66ac6846c58be9493eb270644ee3ce0f86cfea
ToppCell	droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CXCL16 PTDSS2 SUGP2 EPB41L1 S100PBP	7.60e-05	176	110	5	24b2e94ee5defcefb64a1f2447a2cc71b015b0fd
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNC OBSCN ITGA10 AKAP12 CCDC40	7.81e-05	177	110	5	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CXCL16 PTDSS2 SUGP2 EPB41L1 S100PBP	7.81e-05	177	110	5	f360f7099570d248531897b96e0de282e58f59e9
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	RFTN1 ARHGEF40 MDN1 TTC31 BANP	8.23e-05	179	110	5	9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	NID2 TNC RFTN1 ABCG1 ALPK2	8.23e-05	179	110	5	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ADCYAP1 AKAP12 NMT2 MLPH EPB41L1	8.67e-05	181	110	5	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	ABRA ANK3 OBSCN TACC2 ALPK2	8.90e-05	182	110	5	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCYAP1 NMT2 TMEM108 FGF14 ZBTB18	9.61e-05	185	110	5	cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCYAP1 NMT2 TMEM108 FGF14 ZBTB18	9.61e-05	185	110	5	70de48988c1f8e0809afc8092b663aa439d8e528
ToppCell	Control-Myeloid-Macrophage_Alveolar\|World / Disease state, Lineage and Cell class	CXCL16 ABCG1 ALPK3 MLPH EPB41L1	9.61e-05	185	110	5	85cb81759589a26d83676cffbf2bc37399683c10
ToppCell	facs-Heart-Unknown-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABRA OBSCN TXLNB ALPK3 ALPK2	1.01e-04	187	110	5	0ffb988e0da2c7205c3515eca8e9851739bff5c5
ToppCell	facs-Heart-Unknown\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABRA OBSCN TXLNB ALPK3 ALPK2	1.01e-04	187	110	5	362e56426a568423a81e8a30e3ecf99b76135843
ToppCell	facs-Heart-Unknown-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABRA OBSCN TXLNB ALPK3 ALPK2	1.01e-04	187	110	5	c004567767b89f3d89f5c7b28d952f3445957e1e
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPRY3 NID2 AKAP12 IGF1 IL33	1.04e-04	188	110	5	6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNC OBSCN ITGA10 IRAG1 ZNF532	1.04e-04	188	110	5	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ETS2 CXCL16 ADCYAP1 AKAP12 MLPH	1.06e-04	189	110	5	2aebea7a6c2f83112d7c504b742f2c04b92e459a
ToppCell	facs-Heart-LA/RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 OBSCN TXLNB ALPK3 ALPK2	1.06e-04	189	110	5	a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCell	normal_Lung-MAST_cells\|normal_Lung / Location, Cell class and cell subclass	RPS6KA5 ADCYAP1 ARHGEF40 NMT2 MLPH	1.06e-04	189	110	5	f09e387dc0626536050cd537dda212471a7267c4
ToppCell	Control-Myeloid-Macrophage_Alveolar\|Control / Disease state, Lineage and Cell class	CXCL16 ABCG1 ALPK3 MLPH EPB41L1	1.06e-04	189	110	5	937e876122bc4b94372a4104e9c1a9068c232018
ToppCell	normal_Lung-MAST_cells-MAST\|normal_Lung / Location, Cell class and cell subclass	RPS6KA5 ADCYAP1 ARHGEF40 NMT2 MLPH	1.06e-04	189	110	5	fd053209034fca6eaefe0e5ad024ac4548a100c9
ToppCell	facs-Heart-LA/RA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 OBSCN TXLNB ALPK3 ALPK2	1.06e-04	189	110	5	efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCell	CF-Lymphoid-B_cell\|CF / Disease state, Lineage and Cell class	ASXL1 MYCBP2 RFTN1 ZNHIT6 MDN1	1.09e-04	190	110	5	374d8fd63c733178acab07682ed1519693efab45
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNC AKAP12 MDN1 G3BP1 IL33	1.09e-04	190	110	5	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	IPF-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	ARHGAP23 TNC TBC1D2 ETS2 IL33	1.09e-04	190	110	5	4f15842b424eefadbfe451875e517cf70e29607f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNC AKAP12 MDN1 G3BP1 IL33	1.09e-04	190	110	5	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ETS2 CFB IFIH1 OPTN HERC5	1.12e-04	191	110	5	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM3\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABCG1 IGF1 ALPK3 MLPH EPB41L1	1.12e-04	191	110	5	2b10a73c5d80e83d67a7121fb004a1aa86a537ef
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABCG1 IGF1 ALPK3 MLPH EPB41L1	1.12e-04	191	110	5	02e1ae144da7274171e055356d10e8d175c5347f
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 OBSCN TXLNB ALPK3 ALPK2	1.12e-04	191	110	5	c172c9e17b893b290e4aa8af5e5e4cd3e4818372
ToppCell	Severe_COVID-19-Myeloid-TRAM3\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ABCG1 IGF1 ALPK3 MLPH EPB41L1	1.12e-04	191	110	5	05867b96199a46a415848409130697c810d18937
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	ANK3 TNC IRAG1 TMEM108 IL33	1.12e-04	191	110	5	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 OBSCN TXLNB ALPK3 ALPK2	1.12e-04	191	110	5	715f5b449b8e075959c05a5b38389df319663164
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCG1 IGF1 ALPK3 MLPH EPB41L1	1.14e-04	192	110	5	34505a13b8a47c9286c560122fa7861b9c331a08
ToppCell	COVID-19-Myeloid-TRAM1\|COVID-19 / Condition, Lineage and Cell class	CXCL16 ABCG1 IGF1 MLPH EPB41L1	1.14e-04	192	110	5	52b8578699325b0d35a2d3ba36772096130ccc0c
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCG1 IGF1 ALPK3 MLPH EPB41L1	1.14e-04	192	110	5	57c1410ebf90c230993e065eb78385daa3360960
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 OBSCN TACC2 ALPK3 ALPK2	1.17e-04	193	110	5	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	COVID-19-Myeloid-TRAM1\|Myeloid / Condition, Lineage and Cell class	CXCL16 ABCG1 IGF1 MLPH EPB41L1	1.17e-04	193	110	5	6e6a7f4e50c8ae70bc187b9ce77140a7049dd288
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ANK3 RPS6KA5 AKAP12 SUGP2 PCSK7	1.17e-04	193	110	5	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 ARHGAP23 ETS2 TACC2 MLPH	1.17e-04	193	110	5	a5695ce2e24a62026ae28f3dea07ca4a435206b8
ToppCell	CF-Lymphoid\|CF / Disease state, Lineage and Cell class	ASXL1 MYCBP2 RFTN1 ZNHIT6 MDN1	1.17e-04	193	110	5	11de07d13a7da223990b56fa89ba7fc1c3dd0122
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RPS6KA5 ADCYAP1 NMT2 MLPH EPB41L1	1.20e-04	194	110	5	d8f367beab16a3186821e42311947b6c9e99978c
ToppCell	NS-critical-d_07-13-Epithelial-Secretory\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFB ZNHIT6 SOX21 MLPH EPB41L1	1.20e-04	194	110	5	2172d951896265243d14996eacce5aab5e14e26e
ToppCell	COPD-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	TRIO TNC ETS2 MDN1 PRRC2B	1.20e-04	194	110	5	8dcde77767b23e75360adb316cdccf56a00e3726
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 TNC AKAP12 RFTN1 PLA2G4A	1.20e-04	194	110	5	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 TNC AKAP12 RFTN1 PLA2G4A	1.20e-04	194	110	5	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANK3 TACC2 RFTN1 FASN MLPH	1.20e-04	194	110	5	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 OBSCN TACC2 ALPK3 ALPK2	1.23e-04	195	110	5	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	SSB IFIH1 ABCG1 OPTN HERC5	1.23e-04	195	110	5	1992a1673b7213e25f3c76ac77da35c57daceddd
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNC IRAG1 AKAP12 RFTN1 PLA2G4A	1.23e-04	195	110	5	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNC IRAG1 AKAP12 RFTN1 PLA2G4A	1.23e-04	195	110	5	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	ANK3 TACC2 EIF1AY FASN MLPH	1.23e-04	195	110	5	0792c1e959e933b10ae987d821ff43020dfdabad
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RPS6KA5 ADCYAP1 NMT2 MLPH EPB41L1	1.23e-04	195	110	5	f1f48e2e57b2282572959b152aad4bee05143f03
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	ANK3 OBSCN TACC2 ALPK3 ALPK2	1.23e-04	195	110	5	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	normal_Lung-Epithelial_cells\|normal_Lung / Location, Cell class and cell subclass	DDR1 ANK3 TACC2 FASN MLPH	1.23e-04	195	110	5	7c90d887afde5c4d63352b5171be9987e2dfca58
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 RFTN1 PLA2G4A FGF14 IL33	1.23e-04	195	110	5	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDR1 ARHGAP23 TNC SOX21 POLD4	1.23e-04	195	110	5	24d226f89dd337c22728688e4b40ca082a0e1fe1
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_4\|COVID-19_Severe / Disease condition and Cell class	ZBTB43 SSB IFIH1 ABCG1 HERC5	1.23e-04	195	110	5	787ea9f38ad8e2a836222ca97f4d927f7e79517d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNC IRAG1 AKAP12 RFTN1 PLA2G4A	1.23e-04	195	110	5	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RPS6KA5 ADCYAP1 NMT2 MLPH EPB41L1	1.26e-04	196	110	5	e08f90f7a923c2846cac859519b8dc7c0ac7cd03
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNC IRAG1 AKAP12 RFTN1 PLA2G4A	1.26e-04	196	110	5	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	COVID-mDC2\|COVID / Condition, Cell_class and T cell subcluster	ETS2 CXCL16 BCL7A MAGEF1 RCC2	1.26e-04	196	110	5	bb13926bb664be917017edb0ce7f184abe31744b
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ASXL1 RCC2 RFTN1 ZNHIT6 MDN1	1.26e-04	196	110	5	0175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCell	COVID-mDC2-\|COVID / Condition, Cell_class and T cell subcluster	ETS2 CXCL16 BCL7A MAGEF1 RCC2	1.26e-04	196	110	5	6d02a4c5c19be7e036150cf945585cf5a773bc87
ToppCell	10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RPS6KA5 ADCYAP1 NMT2 MLPH EPB41L1	1.26e-04	196	110	5	03710e2a843279124a45a271bffb132835e6081c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NID2 ARHGAP23 TNC AKAP12 IGF1	1.26e-04	196	110	5	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RPS6KA5 ADCYAP1 NMT2 MLPH EPB41L1	1.29e-04	197	110	5	5e4a004052b8560223673a339d4a0d729e533def
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RPS6KA5 ADCYAP1 NMT2 MLPH EPB41L1	1.29e-04	197	110	5	61f909737c5f630beffdd326c6844215643dbdde
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNC IRAG1 AKAP12 RFTN1 PLA2G4A	1.29e-04	197	110	5	80e153790cef37b743e22a7370ff5b3a6abf147d
Drug	Ajmaline [4360-12-7]; Down 200; 12.2uM; HL60; HG-U133A	RBM10 DIDO1 GTPBP1 C2orf68 TTC31 CABIN1 MED12 PRRC2B S100PBP	3.29e-07	193	107	9	1749_DN
Drug	Bretylium tosylate [61-75-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MIA3 ELOA2 TNC TBC1D2 ETS2 PTDSS2 EIF1AY HPX HERC5	3.91e-07	197	107	9	3394_DN
Drug	2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A	ZHX3 ASXL1 RBM10 GPATCH8 BCL7A BANP MARF1 MED12 TBL1X	4.26e-07	199	107	9	346_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A	ASXL1 RBM10 DIDO1 C2orf68 POLD4 CABIN1 MED12 PRRC2B	3.81e-06	194	107	8	1712_DN
Drug	Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A	ASXL1 RPS6KA5 RBM10 RFX5 FASN MDN1 SUGP2 CABIN1	3.81e-06	194	107	8	1547_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A	ZHX3 ASXL1 TBC1D9B TCOF1 ZBTB43 RFTN1 ABCG1 MED12	4.11e-06	196	107	8	7027_DN
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ASXL1 CAMTA2 AKAP12 SUGP2 NMT2 PCSK7 CABIN1 TBL1X	4.27e-06	197	107	8	6218_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A	GBX2 IKZF5 ABCG1 SUGP2 PCSK7 CABIN1 MED12 TBL1X	4.43e-06	198	107	8	2128_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZHX3 MYCBP2 DIDO1 CAMTA2 BCL7A C2orf68 RFTN1 TBL1X	4.43e-06	198	107	8	1650_DN
Drug	Khellin [82-02-0]; Up 200; 15.4uM; PC3; HG-U133A	ASXL1 TCOF1 RBM10 GBX2 TTC31 PCSK7 POLD4 TBL1X	4.78e-06	200	107	8	1922_UP
Drug	Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A	ASXL1 RPS6KA5 GPATCH8 GTPBP1 SUGP2 CABIN1 MLPH HERC5	4.78e-06	200	107	8	1592_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ASXL1 GBX2 BCL7A BANP IL33 MED12 PRRC2B	1.99e-05	176	107	7	1212_DN
Drug	monastrol; Up 200; 100uM; MCF7; HG-U133A	TRIO RB1 GPATCH8 ABCG1 HPX PCSK7 WDR62	3.84e-05	195	107	7	596_UP
Drug	Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A	ELOA2 TRIO ETS2 ITGA10 BCL7A CABIN1 WDR62	3.84e-05	195	107	7	3173_DN
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	NID2 TBC1D9B TCOF1 GBX2 WRAP53 MAGEF1 EPB41L1	3.84e-05	195	107	7	1207_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	ANK3 ZBTB43 RFTN1 OPTN SUGP2 CABIN1 EPB41L1	3.84e-05	195	107	7	5329_DN
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A	ANK3 ZBTB43 CAMTA2 IFIH1 RFTN1 PCSK7 TBL1X	3.84e-05	195	107	7	7413_DN
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A	ZHX3 ASXL1 TBC1D9B RPS6KA5 ABCG1 EPB41L1 TBL1X	3.97e-05	196	107	7	7024_DN
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; PC3; HT_HG-U133A	RPS6KA5 TNC IFIH1 SUGP2 CABIN1 EPB41L1 TBL1X	3.97e-05	196	107	7	1807_DN
Drug	Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A	ZHX3 ANK3 ZBTB43 ETS2 BCL7A SPTBN5 HERC5	3.97e-05	196	107	7	5345_UP
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	ETS2 PTDSS2 MAGEF1 IKZF5 EIF1AY ZNF358 PCSK7	3.97e-05	196	107	7	6610_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; PC3; HT_HG-U133A	TBC1D9B ANK3 TCOF1 ZBTB43 IFIH1 PCSK7 PRRC2B	3.97e-05	196	107	7	5806_DN
Drug	Miconazole [22916-47-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A	C2orf68 AKAP12 ABCG1 SUGP2 EPB41L1 WDR62 TBL1X	4.10e-05	197	107	7	1477_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	ELOA2 TRIO ZBTB43 C2orf68 MAGEF1 IL33 CCDC40	4.10e-05	197	107	7	7504_DN
Drug	Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; PC3; HT_HG-U133A	IKZF5 SPTBN5 ABCG1 IGF1 HPX WDR62 CCDC40	4.10e-05	197	107	7	4598_UP
Drug	Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	TRIO ETS2 WRAP53 GTPBP1 EIF1AY RFTN1 TBL1X	4.23e-05	198	107	7	5532_DN
Drug	copper(II) sulfate pentahydrate; Down 200; 100uM; PC3; HG-U133A	ZHX3 GPATCH8 OPTN SOX21 SUGP2 PCSK7 TBL1X	4.23e-05	198	107	7	459_DN
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; PC3; HT_HG-U133A	ELOA2 ABCG1 IGF1 SUGP2 ZNF358 CABIN1 WDR62	4.23e-05	198	107	7	7320_UP
Drug	1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A	MYCBP2 RBM10 OPTN SOX21 POLD4 CCDC40 S100PBP	4.37e-05	199	107	7	61_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	RPS6KA5 DIDO1 GPATCH8 IKZF5 OPTN PCSK7 WDR62	4.37e-05	199	107	7	1488_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	ZHX3 ZBTB43 EIF1AY SOX21 CABIN1 EPB41L1 WDR62	4.37e-05	199	107	7	4297_DN
Drug	forskolin; Up 200; 50uM; MCF7; HT_HG-U133A_EA	RPS6KA5 ETS2 DIDO1 TACC2 RFTN1 MARF1	9.95e-05	157	107	6	913_UP
Drug	CVT 313	RB1 IGF1	1.30e-04	4	107	2	ctd:C109140
Drug	curcumene	FASN PCSK7	1.30e-04	4	107	2	CID000092139
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	RPS6KA5 TBC1D2 AKAP12 OPTN ARHGEF40 ZBTB18	1.75e-04	174	107	6	5260_UP
Drug	Ketone Bodies	ANK3 TCOF1 MYCBP2 CNOT10 AKAP12 EHMT1 POLD4 FGF14 CABIN1 TP53BP1	1.77e-04	522	107	10	ctd:D007657
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	RPS6KA5 ZBTB43 AKAP12 OPTN ARHGEF40 ZBTB18	1.91e-04	177	107	6	4954_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	RPS6KA5 AKAP12 OPTN ARHGEF40 HPX HERC5	1.91e-04	177	107	6	4821_UP
Drug	Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; PC3; HT_HG-U133A	TNC TACC2 AKAP12 ABCG1 WDR62 TBL1X	2.03e-04	179	107	6	4619_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TRIO RPS6KA5 TBC1D2 SPTBN5 ARHGEF40 HERC5	2.10e-04	180	107	6	3510_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ASXL1 GBX2 BCL7A ZNF358 BANP PRRC2B	2.23e-04	182	107	6	5802_DN
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	ASXL1 TBC1D9B TNC BCL7A MAGEF1 IL33	2.23e-04	182	107	6	1231_DN
Drug	F0447-0125; Down 200; 10uM; PC3; HT_HG-U133A	GBX2 BCL7A WRAP53 C2orf68 TTC31 IL33	2.36e-04	184	107	6	6429_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	MIA3 ANK3 RPS6KA5 NMT2 HPX MARF1	2.50e-04	186	107	6	1664_UP
Drug	trichostatin A; Down 200; 0.1uM; PC3; HG-U133A	ASXL1 RBM10 BCL7A BANP PCSK7 MLPH	2.58e-04	187	107	6	448_DN
Drug	lomustine; Down 200; 100uM; PC3; HT_HG-U133A	TRIO TNC GBX2 WRAP53 C2orf68 CABIN1	2.65e-04	188	107	6	7050_DN
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	ETS2 BCL7A GTPBP1 C2orf68 EPB41L1 WDR62	2.73e-04	189	107	6	6997_DN
Drug	CP-944629 [668990-94-1]; Down 200; 10uM; PC3; HT_HG-U133A	NID2 TBC1D9B ANK3 ETS2 MAGEF1 HERC5	2.89e-04	191	107	6	7549_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	PDC TBC1D2 WRAP53 ABCG1 PLA2G4A HERC5	2.89e-04	191	107	6	2137_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	ZHX3 TRIO ZBTB43 AKAP12 RFTN1 CABIN1	2.89e-04	191	107	6	5200_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	ASXL1 RPS6KA5 TBC1D2 BCL7A FASN MED12	2.89e-04	191	107	6	1080_UP
Drug	Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	TRIO ZBTB43 ETS2 EIF1AY IFIH1 HERC5	2.89e-04	191	107	6	5327_UP
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	RPS6KA5 DIDO1 AKAP12 EIF1AY ABCG1 IL33	2.97e-04	192	107	6	1207_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZHX3 RPS6KA5 AKAP12 RFTN1 PCSK7 EPB41L1	3.05e-04	193	107	6	1644_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ZHX3 ELOA2 TRIO PTDSS2 MAGEF1 ABCG1	3.05e-04	193	107	6	5629_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	RPS6KA5 ITGA10 EIF1AY ABCG1 NMT2 MARF1	3.05e-04	193	107	6	1652_UP
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	TRIO C2orf68 AKAP12 RFTN1 ZNF358 PLA2G4A	3.05e-04	193	107	6	1830_UP
Drug	Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A	ANK3 ETS2 C2orf68 SUGP2 PRRC2B TBL1X	3.14e-04	194	107	6	3303_DN
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A	GBX2 BCL7A EIF1AY OPTN SUGP2 EPB41L1	3.14e-04	194	107	6	4248_DN
Drug	wortmannin; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	ZHX3 TCOF1 ZBTB43 ETS2 PTDSS2 RFTN1	3.22e-04	195	107	6	911_DN
Drug	Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; HL60; HG-U133A	RPS6KA5 RBM10 MARF1 PCSK7 POLD4 MED12	3.22e-04	195	107	6	1966_UP
Drug	Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A	ZBTB43 GTPBP1 MAGEF1 RFTN1 SUGP2 TBL1X	3.22e-04	195	107	6	7004_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	TCOF1 C2orf68 ABCG1 SUGP2 CABIN1 PRRC2B	3.22e-04	195	107	6	3408_DN
Drug	monastrol; Down 200; 100uM; MCF7; HG-U133A	ASXL1 ZBTB43 ITGA10 GPATCH8 BCL7A EPB41L1	3.22e-04	195	107	6	681_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DIDO1 BCL7A C2orf68 IFIH1 RFTN1 ABCG1	3.31e-04	196	107	6	3416_DN
Drug	quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A	BCL7A WRAP53 FASN PCSK7 CABIN1 MED12	3.31e-04	196	107	6	283_UP
Drug	Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A	TBC1D9B TACC2 WRAP53 ABCG1 EPB41L1 WDR62	3.31e-04	196	107	6	6615_DN
Drug	GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; HL60; HG-U133A	ETS2 RFX5 ARHGEF40 TTC31 POLD4 TBL1X	3.31e-04	196	107	6	1625_UP
Drug	Lovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ITGA10 BCL7A PCSK7 CABIN1 WDR62 TBL1X	3.31e-04	196	107	6	4978_DN
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	ZBTB43 ETS2 TACC2 WRAP53 MAGEF1 ZNF358	3.31e-04	196	107	6	6299_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ASXL1 TBC1D9B ZBTB43 ITGA10 OPTN CABIN1	3.31e-04	196	107	6	3183_DN
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; PC3; HT_HG-U133A	ZBTB43 ETS2 PTDSS2 SSB RFX5 CABIN1	3.31e-04	196	107	6	6348_DN
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	CAMTA2 IFIH1 RFTN1 SUGP2 PCSK7 CABIN1	3.31e-04	196	107	6	1685_DN
Drug	Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A	TBC1D9B RPS6KA5 AKAP12 RFTN1 NMT2 PRRC2B	3.31e-04	196	107	6	5505_DN
Drug	wt 340	RB1 IGF1 SCN4A CABIN1	3.33e-04	70	107	4	CID000067945
Drug	Sulpiride [15676-16-1]; Up 200; 11.8uM; PC3; HG-U133A	RPS6KA5 RB1 GTPBP1 ARHGEF40 EPB41L1 PRRC2B	3.40e-04	197	107	6	1887_UP
Drug	Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ASXL1 TCOF1 ETS2 C2orf68 MAGEF1 TBL1X	3.40e-04	197	107	6	6279_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; ssMCF7; HG-U133A	ETS2 SPTBN5 IGF1 SUGP2 PCSK7 TBL1X	3.40e-04	197	107	6	415_UP
Drug	Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; MCF7; HT_HG-U133A	ZHX3 TCOF1 EIF1AY EHMT1 WDR62 TBL1X	3.40e-04	197	107	6	5309_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A	ZHX3 AKAP12 SPTBN5 ABCG1 GSPT2 WDR62	3.40e-04	197	107	6	6936_UP
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ETS2 PTDSS2 RFTN1 SUGP2 PCSK7 EPB41L1	3.40e-04	197	107	6	5500_DN
Drug	pentamidine isethionate salt; Down 200; 100uM; MCF7; HG-U133A	ANK3 TCOF1 C2orf68 SUGP2 PCSK7 TBL1X	3.40e-04	197	107	6	639_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ZBTB43 GTPBP1 AKAP12 RFTN1 ABCG1 SUGP2	3.40e-04	197	107	6	1012_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	ANK3 RBM10 ZBTB43 ETS2 WRAP53 ABCG1	3.40e-04	197	107	6	6585_UP
Drug	genistein; Down 200; 10uM; PC3; HG-U133A	ZHX3 TRIO RBM10 GBX2 BCL7A BANP	3.40e-04	197	107	6	703_DN
Drug	Etodolac [41340-25-4]; Down 200; 14uM; MCF7; HT_HG-U133A	TBC1D2 EIF1AY OPTN EHMT1 CABIN1 WDR62	3.40e-04	197	107	6	2254_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	ASXL1 ZBTB43 IKZF5 PCSK7 CABIN1 MED12	3.40e-04	197	107	6	6935_DN
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	ZHX3 ZBTB43 ETS2 FASN PCSK7 TBL1X	3.40e-04	197	107	6	1183_DN
Drug	chlorpropamide; Up 200; 100uM; MCF7; HG-U133A	ANK3 GTPBP1 SPTBN5 SOX21 SUGP2 TP53BP1	3.40e-04	197	107	6	141_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA	TBC1D9B ANK3 ZBTB43 CAMTA2 MAGEF1 TBL1X	3.40e-04	197	107	6	1055_UP
Drug	Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A	TRIO TCOF1 NMT2 PCSK7 MED12 EPB41L1	3.40e-04	197	107	6	6216_DN
Drug	radicicol; Down 200; 0.1uM; PC3; HG-U133A	TRIO SPTBN5 SOX21 SUGP2 EPB41L1 PRRC2B	3.40e-04	197	107	6	449_DN
Drug	S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A	TRIO MYCBP2 ZBTB43 BCL7A WRAP53 RFTN1	3.40e-04	197	107	6	5311_DN
Drug	Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A	CAMTA2 C2orf68 ZNF358 NMT2 ALPK3 PLA2G4A	3.50e-04	198	107	6	2060_UP
Drug	Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	TRIO PTDSS2 BCL7A IFIH1 ABCG1 TBL1X	3.50e-04	198	107	6	7010_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	MIA3 TBC1D9B CAMTA2 C2orf68 MAGEF1 PRRC2B	3.50e-04	198	107	6	1237_DN
Drug	Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A	TRIO ZBTB43 ETS2 WRAP53 IKZF5 EIF1AY	3.50e-04	198	107	6	5361_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MIA3 DIDO1 CAMTA2 C2orf68 AKAP12 CCDC40	3.50e-04	198	107	6	4367_DN
Drug	Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A	ZHX3 ANK3 ITGA10 PTDSS2 RFTN1 SUGP2	3.50e-04	198	107	6	6275_UP
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A	TCOF1 BCL7A EHMT1 ACAP2 EPB41L1 WDR62	3.50e-04	198	107	6	6263_UP
Disease	uveal melanoma (implicated_via_orthology)	EIF1AY EIF1AX	1.23e-05	2	104	2	DOID:6039 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	NID2 TBC1D9B RB1 OBSCN ETS2 TACC2 AKAP12 FASN IGF1 ZNF532 EHMT1 PLA2G4A MED12 TP53BP1	2.48e-05	1074	104	14	C0006142
Disease	polycystic kidney disease (biomarker_via_orthology)	TNC CFB PLA2G4A	3.96e-05	19	104	3	DOID:0080322 (biomarker_via_orthology)
Disease	muscular disease (implicated_via_orthology)	FASN NMT2	1.22e-04	5	104	2	DOID:0080000 (implicated_via_orthology)
Disease	paracoccidioidomycosis (is_marker_for)	CFB IL33	2.55e-04	7	104	2	DOID:12662 (is_marker_for)
Disease	left ventricular structural measurement	ABRA ZHX3 ZNF358 ALPK3	2.71e-04	88	104	4	EFO_0008205
Disease	Squamous cell carcinoma of esophagus	RB1 DIDO1 ADCYAP1 FASN	3.62e-04	95	104	4	C0279626
Disease	pleural tuberculosis (is_marker_for)	TNC IL33	5.44e-04	10	104	2	DOID:106 (is_marker_for)
Disease	Mammary Carcinoma, Human	RB1 ETS2 AKAP12 FASN IGF1 PLA2G4A MED12 TP53BP1	5.51e-04	525	104	8	C4704874
Disease	Mammary Neoplasms, Human	RB1 ETS2 AKAP12 FASN IGF1 PLA2G4A MED12 TP53BP1	5.51e-04	525	104	8	C1257931
Disease	Mammary Neoplasms	RB1 ETS2 AKAP12 FASN IGF1 PLA2G4A MED12 TP53BP1	5.65e-04	527	104	8	C1458155
Disease	Breast Carcinoma	RB1 ETS2 AKAP12 FASN IGF1 PLA2G4A MED12 TP53BP1	6.46e-04	538	104	8	C0678222
Disease	Kidney Failure, Chronic	FASN ABCG1 IGF1	6.56e-04	48	104	3	C0022661
Disease	forced expiratory volume, body mass index	C6orf89 IGF1	6.63e-04	11	104	2	EFO_0004314, EFO_0004340
Disease	suicide	IRAG1 AKAP12 RP1L1	7.39e-04	50	104	3	EFO_0007624
Disease	Metastatic melanoma	TRIO ALPK3 ALPK2	9.26e-04	54	104	3	C0278883
Disease	Nasal Cavity Polyp	MIA3 GIGYF2 IL33	9.77e-04	55	104	3	EFO_1000391
Disease	Hypertrophic Cardiomyopathy	OBSCN FASN ALPK3	1.08e-03	57	104	3	C0007194
Disease	tumor necrosis factor measurement	C6orf89 HPX	1.25e-03	15	104	2	EFO_0010834
Disease	osteosarcoma (is_implicated_in)	DDR1 RB1	1.43e-03	16	104	2	DOID:3347 (is_implicated_in)
Disease	Adrenocortical carcinoma	RB1 MED12	1.81e-03	18	104	2	C0206686
Disease	PR interval	HDGFL1 MYCBP2 OBSCN ARHGEF40 ZNF358 ALPK3 FGF14	1.88e-03	495	104	7	EFO_0004462
Disease	unipolar depression, response to bupropion, mood disorder	ZHX3 TNC	2.02e-03	19	104	2	EFO_0003761, EFO_0004247, EFO_0006326

Protein segments in the cluster

Peptide	Gene	Start	Entry
VPGQEDSHHEDGESG	BANP	166	Q8N9N5
TSDNGGHLEPLDGAV	ARSH	321	Q5FYA8
SPGDKEDASHQEALG	ARHGEF40	401	Q8TER5
SDHKRDLGGDAEVNP	ABCG1	351	P45844
KFTDGDLNNDGPHDE	ALPK2	241	Q86TB3
GEGAAGAGDHKDPSL	AKAP12	206	Q02952
GAGDHKDPSLGAGEA	AKAP12	211	Q02952
HQLEDKAAEGAPGDG	DDR1	716	Q08345
EGNVVNKPDSHGGSL	GTPBP1	221	O00178
DGSPKNDDGHKTEQP	GZF1	611	Q9H116
EAAPENGEDGEHGLL	ALPK3	481	Q96L96
DDDSGEELKGHGAAP	CAMTA2	446	O94983
GHSLAAGPEAGENQK	CXCL16	176	Q9H2A7
AGHSKGELAPELGEE	POLD4	21	Q9HCU8
RGANQHATDEEGKDP	ACAP2	696	Q15057
DNTEGVSKPDGFQEH	BBS12	241	Q6ZW61
QGDDPGKVSEKVSAH	C2orf68	126	Q2NKX9
DTLEKGTGQALDSHP	ASXL1	821	Q8IXJ9
GSDEADGSKHLPGES	RB1	881	P06400
GKAGGAAVVITEPEH	RCC2	76	Q9P258
VPALEQSADGHKETG	RBM10	616	P98175
DHASLENEKPGTGDV	RFTN1	196	Q14699
GDQGPHDKGVKRTAE	RFX5	421	P48382
DAEDGHGPGEQQKRK	CFB	246	P00751
GNGTHGLSPEEKEQL	ELOA2	326	Q8IYF1
SVSENHDAGPDGDKR	EPB41L1	441	Q9H4G0
GAAPEKEQGKEEHGS	MDN1	5051	Q9NU22
EGEKDGGHDGETRAP	MAGEF1	16	Q9HAY2
DEHDENGATGPVKRA	SSB	371	P05455
GDNEEETEHAKGSPG	NMT2	26	O60551
AAEGDEDKPTHAGGG	HDGFL1	111	Q5TGJ6
QQKGDEADVSSPHPG	IRAG1	226	Q9Y6F6
EHSKEVSEAEPGGGS	GSPT2	151	Q8IYD1
GSSSKDHLQGLDPGE	GPATCH8	596	Q9UKJ3
DDDGKTVDGPHQLGK	PCSK7	291	Q16549
EDFEGQATHTGPKGV	PDC	11	P20941
GTPKDHDSPENGADS	ETS2	271	P15036
HPDGALDGTKDDSTN	FGF14	86	Q92915
EHAKINETDTFGPGD	EIF1AY	111	O14602
GLGPSKDGHEISSDD	MED12	486	Q93074
ADGGDGGEQLLTVKH	RPS6KA5	16	O75582
GTDGDQNGLDHPSVE	IKZF5	46	Q9H5V7
GQLGLGHTESKDDPS	HERC5	221	Q9UII4
VLGGDNEPDSEKQSH	OBSCN	6446	Q5VST9
LDPHTKEGTSLGEVG	NID2	361	Q14112
AGDDAEPLSKRHSDG	ADCYAP1	121	P18509
DNLTGQAAHKEEDPG	GBX2	211	P52951
SQHPSNESGDGVDGK	IL33	166	O95760
GHGEHLDSEGEEAPQ	GOLGA8K	426	D6RF30
AVSSGDEKEGLKHPG	CABIN1	71	Q9Y6J0
NFEEGGPTSVGRKHE	GIGYF2	181	Q6Y7W6
VHGGLDSNGKPADAV	G3BP1	41	Q13283
SHPEDGSASEGEKEG	CCDC40	11	Q4G0X9
GAPEQAAAGKSHGDL	CRYBB3	6	P26998
PGVGGATKQAKAEEH	IFIH1	491	Q9BYX4
ENEGKSGGGLHSVAE	ZNHIT6	6	Q9NWK9
PASSEKVKGGDDHDD	DIDO1	136	Q9BTC0
EHTSEGKSGDQGEGD	ANK3	3636	Q12955
GGSGLGIPSDNEKHD	BPESC1	41	Q9GZL8
ELKLGADGSGPSHTE	MARF1	1596	Q9Y4F3
DGESHDGEELPAALK	ITGA10	276	O75578
DFVGEKLGSGEPSHS	ATE1	171	O95260
KNTSPEHGGRGSEDE	CEP192	966	Q8TEP8
HPGGEQKEGTEASLQ	IGF1	156	P05019
HGGEHLDSEGEEAPQ	GOLGA8R	426	I6L899
MSENKGVPLHGGDED	C6orf89	116	Q6UWU4
EAHGTGTKVGDPQEL	FASN	291	P49327
QADGKEHPGAEDASD	BCL7A	136	Q4VC05
QSSGEDDGGHVEKGE	S100PBP	71	Q96BU1
EDDKLQGAASHVPEG	EHMT1	681	Q9H9B1
AAPHKAEGLEEADTG	MLPH	236	Q9BV36
SHEPKGTENEDAGSD	PLA2G4A	441	P47712
NPVAGLETDDHGGKA	FAM174A	86	Q8TBP5
GEAEGSVKEIKHSPG	OPTN	186	Q96CV9
AHGNVAEGETKPDPD	HPX	31	P02790
GGVADAEHPALKAGA	SOX21	101	Q9Y651
GAPDSSIPDDHQGEK	WRAP53	521	Q9BUR4
SIPDDHQGEKGQGGT	WRAP53	526	Q9BUR4
HSHDGSGDDAPEKEG	SCN4A	1756	P35499
DNPEEHLKTSGLAGE	MIA3	856	Q5JRA6
SEEDGEGPQGAKSAH	TCOF1	1156	Q13428
KDDQGSTVGNGDQHP	PTDSS2	451	Q9BVG9
DVSKQLHSGGPENDV	KNSTRN	121	Q9Y448
KLFELGPDGGDHETD	MYCBP2	1281	O75592
DGALKGEAEQSAGHP	SPRY3	126	O43610
QAAKGGESLGEDPEH	SPTBN5	1751	Q9NRC6
AGGDTHLGKAPQESQ	TBC1D9B	1111	Q66K14
PEGHGDGQSSEKAPE	ABRA	86	Q8N0Z2
PADQGAEKHEGTGQS	CNOT10	6	Q9H9A5
ELGSGGHTDFPKAQE	ZBTB43	156	O43298
GGHDVPSNKDVTSLD	TBL1X	281	O60907
IDSSEGGEKDGHNPT	ZNF532	71	Q9HCE3
EVTAESQEALGPGKH	ZSCAN20	221	P17040
DDHSLEGLGEPAQAG	RP1L1	996	Q8IWN7
HGQELSEASSPDGKG	RP1L1	1406	Q8IWN7
DDSEQEAHKPGAGAT	ARHGAP23	1191	Q9P227
KEEDSLGAGTHPDAA	USP35	731	Q9P2H5
QAGGEAEPHATAAGK	ZBTB18	196	Q99592
PGGTKNEVTAHELGE	ZNF75CP	131	Q92670
PSEGEGLGADGQEHK	SUGP2	1046	Q8IX01
SGGDHAEVDVPKSQQ	TNC	931	P24821
DSEQGSGQSKEHRPG	PRRC2B	1726	Q5JSZ5
QVSDLGSKGEHPEGD	TACC2	471	O95359
VETHDPILGSGKGDS	TP53BP1	961	Q12888
GDEGSLLKVHVDPSG	WDR62	671	O43379
SHNGLEKEDGQDSPT	TXLNB	26	Q8N3L3
DQGPGTGELTAVHKG	ZHX3	901	Q9H4I2
KQAQGTGHEPPGEDS	TBC1D2	226	Q9BYX2
CGGADKLGPNSETDH	TRIO	1041	O75962
LGHLDDEGKSTGQSD	TTC31	81	Q49AM3
VESSDPKAGHDAGPD	ZNF358	491	Q9NW07
PGTAGNISHVAEGDK	TMEM108	441	Q6UXF1
QEASEEPPAHKDRGG	nan	66	Q8N402
EHAKINETDTFGPGD	EIF1AX	111	P47813